tradingkey.logo

Kestra Medical Technologies Ltd

KMTS
查看詳細走勢圖
25.470USD
+0.350+1.39%
收盤 02/06, 16:00美東報價延遲15分鐘
1.31B總市值
虧損本益比TTM

Kestra Medical Technologies Ltd

25.470
+0.350+1.39%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.39%

5天

+3.24%

1月

-4.43%

6月

+72.68%

今年開始到現在

-3.96%

1年

0.00%

查看詳細走勢圖

操作建議

Kestra Medical Technologies Ltd當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值合理,在醫療設備與耗材行業排名37/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為29.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Kestra Medical Technologies Ltd評分

相關信息

行業排名
37 / 205
全市場排名
125 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看跌

Kestra Medical Technologies Ltd亮點

亮點風險
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
業績增長期
公司處於發展階段,最新年度總收入59.81M美元
估值合理
公司最新PE估值-9.23,處於3年歷史合理位
機構加倉
最新機構持股50.34M股,環比增加1.70%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉1.27M股

分析師目標

基於 7 分析師
買入
評級
29.000
目標均價
+13.37%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Kestra Medical Technologies Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Kestra Medical Technologies Ltd簡介

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
公司代碼KMTS
公司Kestra Medical Technologies Ltd
CEOWebster (Brian Daniel)
網址
KeyAI